Potential Uses of Probiotics in Clinical Practice

SUMMARY Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. There is now mounting evidence that selected probiotic strains can provide health benefits to their human hosts. Numerous clinical trials show that certain strains can improve the outcome of intestinal infections by reducing the duration of diarrhea. Further investigations have shown benefits in reducing the recurrence of urogenital infections in women, while promising studies in cancer and allergies require research into the mechanisms of activity for particular strains and better-designed trials. At present, only a small percentage of physicians either know of probiotics or understand their potential applicability to patient care. Thus, probiotics are not yet part of the clinical arsenal for prevention and treatment of disease or maintenance of health. The establishment of accepted standards and guidelines, proposed by the Food and Agriculture Organization of the United Nations and the World Health Organization, represents a key step in ensuring that reliable products with suitable, informative health claims become available. Based upon the evidence to date, future advances with single- and multiple-strain therapies are on the horizon for the management of a number of debilitating and even fatal conditions.

[1]  T. Klaenhammer,et al.  Identification of the pH‐inducible, proton‐translocating F1F0‐ATPase (atpBEFHAGDC) operon of Lactobacillus acidophilus by differential display: gene structure, cloning and characterization , 1999, Molecular microbiology.

[2]  S. Gorbach Probiotics and gastrointestinal health. , 2000, The American journal of gastroenterology.

[3]  A. Servin,et al.  Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. , 1993, FEMS microbiology letters.

[4]  I. Julkunen,et al.  Lactobacilli and Streptococci Activate NF-κB and STAT Signaling Pathways in Human Macrophages1 , 2000, The Journal of Immunology.

[5]  P. Hay Recurrent bacterial vaginosis , 2000, Dermatologic clinics.

[6]  R. Mackie,et al.  Developmental microbial ecology of the neonatal gastrointestinal tract. , 1999, The American journal of clinical nutrition.

[7]  J. Hamilton-miller,et al.  Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. , 1998, The Journal of antimicrobial chemotherapy.

[8]  G. Barnes,et al.  Enteric Colonization in Sporadic Neonatal Necrotizing Enterocolitis , 1985, Journal of pediatric gastroenterology and nutrition.

[9]  A. Bruce,et al.  The influence of nonoxynol-9-containing spermicides on urogenital infection. , 1994, The Journal of urology.

[10]  S. Salminen,et al.  Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial , 2003, The Lancet.

[11]  John E. Linz,et al.  Binding of aflatoxin B1 to bifidobacteria in vitro. , 2000, Journal of food protection.

[12]  S. Guandalini Use of Lactobacillus-GG in paediatric Crohn's disease. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  G. Reid,et al.  Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. , 2003, FEMS immunology and medical microbiology.

[14]  G. Belle,et al.  Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. , 1989, Gastroenterology.

[15]  I. Julkunen,et al.  Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. , 2000, Journal of immunology.

[16]  P. Brigidi,et al.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.

[17]  J. Pestka,et al.  Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells1 , 2002, The Journal of Immunology.

[18]  F. Shanahan Therapeutic Manipulation of Gut Flora , 2000, Science.

[19]  A. Bruce,et al.  Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. , 1987, The Journal of urology.

[20]  R. Black,et al.  A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. , 1999, The Journal of pediatrics.

[21]  G. Reid,et al.  Oral Administration of the Probiotic Combination Lactobacillus Rhamnosus GR-1 and L. Fermentum RC-14 for Human Intestinal Applications , 2002 .

[22]  B. Birkenfeld,et al.  A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome , 2001, European journal of gastroenterology & hepatology.

[23]  B. Goldin,et al.  Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. , 1987, Journal of dairy science.

[24]  S. Salminen,et al.  Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B, from the chicken duodenum. , 2000, Journal of food protection.

[25]  J. Hunter,et al.  A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics , 2002, British Journal of Nutrition.

[26]  H. Kauma,et al.  Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  J. Thorp,et al.  Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. , 1999, Sexually transmitted diseases.

[28]  H. Mykkänen,et al.  Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. , 1997, The Pediatric infectious disease journal.

[29]  D. Seehofer,et al.  Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients , 2002, Transplantation.

[30]  G. Reid,et al.  Lactobacillus strains and vaginal ecology. , 2002, JAMA.

[31]  G. Dallabetta,et al.  Sexually transmitted infections and associated socio‐demographic and behavioural factors in women seeking primary care suggest Madagascar’s vulnerability to rapid HIV spread , 2001, Tropical medicine & international health : TM & IH.

[32]  A. Schaeffer Pilot Trial of Bacterial Interference for Preventing Urinary Tract Infection , 2002 .

[33]  Gregor Reid,et al.  In vitro testing of Lactobacillus acidophilus NCFMTM as a possible probiotic for the urogenital tract , 2000 .

[34]  W. Walker Role of nutrients and bacterial colonization in the development of intestinal host defense. , 2000, Journal of pediatric gastroenterology and nutrition.

[35]  Y. Koga,et al.  Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model , 1998, American Journal of Gastroenterology.

[36]  H. Akaza,et al.  Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. , 1995, European urology.

[37]  A. Servin,et al.  Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB , 1997, Antimicrobial agents and chemotherapy.

[38]  P. Midolo,et al.  In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. , 1995, The Journal of applied bacteriology.

[39]  C. Prantera,et al.  Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG , 2002, Gut.

[40]  G. Reid,et al.  Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. , 2002, The Journal of infectious diseases.

[41]  J. Laman,et al.  Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. , 2000, Vaccine.

[42]  J. Bartlett,et al.  Clinical practice. Antibiotic-associated diarrhea. , 2002, New England Journal of Medicine.

[43]  S. Ahrné,et al.  Vaginal Lactobacillus Flora of Healthy Swedish Women , 2002, Journal of Clinical Microbiology.

[44]  M. Teixeira,et al.  IL-1-Driven Endogenous IL-10 Production Protects Against the Systemic and Local Acute Inflammatory Response Following Intestinal Reperfusion Injury1 , 2003, The Journal of Immunology.

[45]  K. Kataoka,et al.  Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. , 1997, Biochemical and biophysical research communications.

[46]  M. Hollingsworth,et al.  Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[47]  G. Reid,et al.  Differentiation of Lactobacillus Species by Molecular Typing , 1998, Applied and Environmental Microbiology.

[48]  S. Kamiya,et al.  Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. , 1997, Gut.

[49]  A. Hosono,et al.  Effect of administration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenicity and microflora in the human intestine. , 1996, Journal of dairy science.

[50]  T. Matsuzaki,et al.  Modulating immune responses with probiotic bacteria , 2000, Immunology and cell biology.

[51]  D R Hoover,et al.  Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV , 1998, AIDS.

[52]  L. Saif,et al.  Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. , 1996, The Journal of general virology.

[53]  H. Mykkänen,et al.  Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. , 1997, Journal of pediatric gastroenterology and nutrition.

[54]  G. Reid,et al.  Urogenital Lactobacilli Probiotics, Reliability, and Regulatory Issues , 2001 .

[55]  S. Salminen,et al.  Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial , 2001, The Lancet.

[56]  H. Gill,et al.  Systemic Immunity-Enhancing Effects in Healthy Subjects Following Dietary Consumption of the Lactic Acid Bacterium Lactobacillus rhamnosus HN001 , 2001, Journal of the American College of Nutrition.

[57]  A. Gasbarrini,et al.  A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates , 2000, Alimentary pharmacology & therapeutics.

[58]  A. Hoyos Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. , 1999, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[59]  A. Etzioni,et al.  Evaluation of a Diet Containing Probiotics and Zinc for the Treatment of Mild Diarrheal Illness in Children Younger Than One Year of Age , 2005, Journal of the American College of Nutrition.

[60]  M. Nader-Macías,et al.  Selection of Vaginal H2O2-Generating Lactobacillus Species for Probiotic Use , 1999, Current Microbiology.

[61]  A. Blum,et al.  Effect of Whey-Based Culture Supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori Infection in Humans , 1999, Digestion.

[62]  C. Locht,et al.  Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. , 2002, Vaccine.

[63]  D. Brassart,et al.  The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo , 1997, Applied and environmental microbiology.

[64]  G. Perdigón,et al.  Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections , 1991, Journal of Dairy Research.

[65]  A. Guarino,et al.  Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. , 1997, Journal of pediatric gastroenterology and nutrition.

[66]  P. Marteau,et al.  On the safety of lactic acid bacteria from food. , 1995, International journal of food microbiology.

[67]  R. Macdermott Alterations of the mucosal immune system in inflammatory bowel disease. , 1996, Journal of gastroenterology.

[68]  M. Médici,et al.  Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. , 2000, Journal of dairy science.

[69]  L. Edmunds The underuse of probiotics by family physicians. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[70]  Jenny Wang,et al.  Isolation of Gemmata-Like and Isosphaera-Like Planctomycete Bacteria from Soil and Freshwater , 2002, Applied and Environmental Microbiology.

[71]  T. Koivula,et al.  A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. , 1991, Pediatrics.

[72]  A. Bruce,et al.  Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. , 2001, FEMS immunology and medical microbiology.

[73]  S. Hillier,et al.  Microbiologic Characteristics of Lactobacillus Products Used for Colonization of the Vagina , 1990, Obstetrics and gynecology.

[74]  H. Holst,et al.  [Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study]. , 1993, Fortschritte der Medizin.

[75]  M. Ferenčík,et al.  Combination Treatment of Rat Adjuvant‐Induced Arthritis with Methotrexate, Probiotic Bacteria Enterococcus faecium, and Selenium , 2005, Annals of the New York Academy of Sciences.

[76]  G. Reid,et al.  Ability of Lactobacillus GR - 1 and RC - 14 to Stimulate Host Defences and Reduce Gut Translocation and Infectivity of Salmonella typhimurium , 2002 .

[77]  A. Bruce,et al.  Selection of lactobacillus strains for urogenital probiotic applications. , 2001, The Journal of infectious diseases.

[78]  E. Soppi,et al.  Enhancement of the Circulating Antibody Secreting Cell Response in Human Diarrhea by a Human Lactobacillus Strain , 1992, Pediatric Research.

[79]  J. Jacquemin,et al.  Possible Role of Catheters in Saccharomyces boulardii Fungemia , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[80]  G. Reid Safety of lactobacillus strains as probiotic agents. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  C. Dani,et al.  Probiotics Feeding in Prevention of Urinary Tract Infection, Bacterial Sepsis and Necrotizing Enterocolitis in Preterm Infants , 2002, Neonatology.

[82]  D. Jungkind,et al.  Prevalence and Acquisition of Vancomycin-Resistant Enterococci in a Medical Intensive Care Unit , 2002, Infection Control & Hospital Epidemiology.

[83]  L. Hammarström,et al.  Lactobacillus paracasei Strain ST11 Has No Effect on Rotavirus but Ameliorates the Outcome of Nonrotavirus Diarrhea in Children From Bangladesh , 2005, Pediatrics.

[84]  R. Yolken,et al.  Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus , 1994, The Lancet.

[85]  D. Taylor-Robinson,et al.  Bacterial vaginosis in climacteric and menopausal women , 2002, International journal of STD & AIDS.

[86]  S. Boris,et al.  Potential role of lactobacilli as prophylactic agents against genital pathogens. , 1999, AIDS patient care and STDs.

[87]  P. Gopal,et al.  In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. , 2001, International journal of food microbiology.

[88]  P. Gopal,et al.  Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). , 2000, The British journal of nutrition.

[89]  M. Saxelin,et al.  Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis , 1995, Journal of pediatric gastroenterology and nutrition.

[90]  M. Millar,et al.  Enteral feeding of premature infants with Lactobacillus GG. , 1993, Archives of disease in childhood.

[91]  A. Blum,et al.  Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man , 2001, European journal of gastroenterology & hepatology.

[92]  Marie-Hélène Coconnier-Polter,et al.  pH-, Lactic Acid-, and Non-Lactic Acid-Dependent Activities of Probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium , 2005, Applied and Environmental Microbiology.

[93]  G. Reid,et al.  Improved Understanding of the Bacterial Vaginal Microbiota of Women before and after Probiotic Instillation , 2003, Applied and Environmental Microbiology.

[94]  H. Bisgaard,et al.  Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. , 2002, The Journal of allergy and clinical immunology.

[95]  A. Flahault,et al.  Antibiotic‐associated diarrhoea and Clostridium difficile> in the community , 2003, Alimentary pharmacology & therapeutics.

[96]  J. Schwebke,et al.  Correlation of behaviors with microbiological changes in vaginal flora. , 1999, The Journal of infectious diseases.

[97]  S. Hillier,et al.  The vaginal microbial ecosystem and resistance to HIV. , 1998, AIDS research and human retroviruses.

[98]  D. Hamer,et al.  From the farm to the kitchen table: the negative impact of antimicrobial use in animals on humans. , 2002, Nutrition reviews.

[99]  J. Thomas LaMont,et al.  Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa , 1999, Infection and Immunity.

[100]  C. Surawicz,et al.  The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[101]  A. Oláh,et al.  Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis , 2002, The British journal of surgery.

[102]  G. Perdigón,et al.  Mechanisms Involved in the Immunostimulation by Lactic Acid Bacteria , 2000 .

[103]  Matthew R. Thomas,et al.  Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. , 2001, Mayo Clinic proceedings.

[104]  C. Bulpitt,et al.  Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis , 2002, BMJ : British Medical Journal.

[105]  G. Reid,et al.  Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but Not L. rhamnosus GG in the Human Vagina as Demonstrated by Randomly Amplified Polymorphic DNA , 2002, Clinical and Vaccine Immunology.

[106]  R. Gray,et al.  HIV infection and disturbances of vaginal flora during pregnancy. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[107]  D. Brassart,et al.  Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. , 1994, Gut.

[108]  E. Ledru,et al.  HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis , 1997, The Lancet.

[109]  W. Verstraete,et al.  Evaluation of nitric oxide production by lactobacilli , 2001, Applied Microbiology and Biotechnology.

[110]  H. Szajewska,et al.  Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. , 1998, Journal of pediatric gastroenterology and nutrition.

[111]  C. Surawicz,et al.  Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. , 1995, The American journal of gastroenterology.

[112]  H. Gill,et al.  Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. , 2002, FEMS immunology and medical microbiology.

[113]  A. Challa,et al.  Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. , 1997, Carcinogenesis.

[114]  R. Glass,et al.  Estimates of morbidity and mortality rates for diarrheal diseases in American children. , 1991, The Journal of pediatrics.

[115]  M. Millar,et al.  Enteral feeding of premature infants with Lactobacillus GG. , 1993, Archives of disease in childhood.

[116]  K. Nelson,et al.  Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand , 1995, AIDS.

[117]  P. Panigrahi,et al.  Stool microflora in extremely low birthweight infants , 1999, Archives of disease in childhood. Fetal and neonatal edition.

[118]  R. Fao,et al.  Regulatory and clinical aspects of dairy probiotics , 2001 .

[119]  O Lundgren,et al.  Pathogenesis of Rotavirus diarrhea , 2001, Microbes and Infection.

[120]  A. Bruce,et al.  Oral probiotics can resolve urogenital infections. , 2001, FEMS immunology and medical microbiology.

[121]  A. Onderdonk,et al.  Nugent Score Related to Vaginal Culture in Pregnant Women , 2001, Obstetrics and gynecology.

[122]  J. Hunter,et al.  Effect of Lactobacillus plantarum 299v on Colonic Fermentation and Symptoms of Irritable Bowel Syndrome , 2002, Digestive Diseases and Sciences.

[123]  A. Servin,et al.  Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection , 1997, Applied and environmental microbiology.

[124]  T. Tompkins,et al.  Probiotics Reduce Enterohemorrhagic Escherichia coli O157:H7- and Enteropathogenic E. coli O127:H6-Induced Changes in Polarized T84 Epithelial Cell Monolayers by Reducing Bacterial Adhesion and Cytoskeletal Rearrangements , 2005, Infection and Immunity.

[125]  J. Mrukowicz,et al.  Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. , 2001, The Journal of pediatrics.

[126]  M. Pochapin The effect of probiotics on Clostridium difficile diarrhea. , 2000, The American journal of gastroenterology.

[127]  D. Taylor-Robinson,et al.  A longitudinal study of the vaginal flora over a menstrual cycle , 1997, International journal of STD & AIDS.

[128]  S. Salminen,et al.  Probiotics in the management of atopic eczema , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[129]  D. Seehofer,et al.  Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. , 2002, Nutrition.

[130]  G. W. Smith,et al.  Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine. , 1983, The Journal of urology.

[131]  E. Isolauri,et al.  Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. , 1996, The Journal of allergy and clinical immunology.

[132]  P. Sneath,et al.  Approved lists of bacterial names. , 1980, The Medical journal of Australia.

[133]  M. Hollingsworth,et al.  Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[134]  A. Donnet-Hughes,et al.  Lipoteichoic Acids from Lactobacillus johnsonii Strain La1 and Lactobacillus acidophilus Strain La10 Antagonize the Responsiveness of Human Intestinal Epithelial HT29 Cells to Lipopolysaccharide and Gram-Negative Bacteria , 2002, Infection and Immunity.

[135]  W. Holzapfel,et al.  Enterococci at the crossroads of food safety? , 1999, International journal of food microbiology.

[136]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.

[137]  B. Chohan,et al.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. , 1999, The Journal of infectious diseases.

[138]  R. Clemens,et al.  Probiotic spectra of lactic acid bacteria (LAB). , 1999, Critical reviews in food science and nutrition.

[139]  R. Chandra,et al.  Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019) , 2000, European Journal of Clinical Nutrition.

[140]  L. Ozimek,et al.  Lack of Therapeutic Effect of a Specially Designed Yogurt for the Eradication of Helicobacter pylori Infection , 2002, Digestion.

[141]  R. Yolken,et al.  Intestinal mucins inhibit rotavirus replication in an oligosaccharide-dependent manner. , 1994, The Journal of infectious diseases.

[142]  P. Marteau Probiotics in clinical conditions , 2002, Clinical reviews in allergy & immunology.

[143]  T. Cole,et al.  Breast milk and neonatal necrotising enterocolitis , 1990, The Lancet.

[144]  N. Sipsas,et al.  Safety of Lactobacillus strains used as probiotic agents. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[145]  G. Reid,et al.  Implantation of Lactobacillus casei var rhamnosus into vagina , 1994, The Lancet.

[146]  S. Salminen,et al.  Probiotics: effects on immunity. , 2001, The American journal of clinical nutrition.

[147]  M. Caplan,et al.  Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. , 2000, Journal of pediatric gastroenterology and nutrition.

[148]  A. Servin,et al.  Antagonistic Activity againstHelicobacter Infection In Vitro and In Vivo by the HumanLactobacillus acidophilus Strain LB , 1998, Applied and Environmental Microbiology.

[149]  P. Wadhwa,et al.  Maternal Stress is Associated With Bacterial Vaginosis in Human Pregnancy , 2001, Maternal and Child Health Journal.